Busy week ahead.In biotech, Mylan - MYL - and Horizon Pharma HZNP - kick off the week. Valeant Pharma - VRX - reports. Any earnings or revenue beat will send the stock back to $15/share. Synergy Pharma - SGYP - needs better script numbers to give the stock a permanent boost. Endo International - ENDP - a generic giant, reports at the end of the month. Elsewhere, expet good news from Etsy and Take-Two - TTWO. Snap Inc. reports after tuesday’s close. Snap will not likely beat consensus but FB, TWTR both reported a good quarter. Chances are low that SNAP will miss its lower outlook: $SNAP, Snap Inc. / H1 On Thursday, Nvidia - NVDA - needs a blowout quarter to justify the $205+ share price. Himax Technologies - HIMX - will surely report good progress for its capex spend. analysts are against HIMX stock.